111 Capital Buys 2,649 Shares of Danaher Corporation $DHR

111 Capital grew its stake in shares of Danaher Corporation (NYSE:DHR) by 81.3% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 5,908 shares of the conglomerate’s stock after purchasing an additional 2,649 shares during the period. 111 Capital’s holdings in Danaher were worth $1,167,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently made changes to their positions in the company. Ameriflex Group Inc. increased its position in Danaher by 95.8% in the 2nd quarter. Ameriflex Group Inc. now owns 374 shares of the conglomerate’s stock valued at $75,000 after buying an additional 183 shares in the last quarter. Franklin Street Advisors Inc. NC grew its stake in Danaher by 39.4% in the second quarter. Franklin Street Advisors Inc. NC now owns 2,886 shares of the conglomerate’s stock valued at $570,000 after acquiring an additional 815 shares during the period. Barrett & Company Inc. increased its holdings in shares of Danaher by 96.2% during the second quarter. Barrett & Company Inc. now owns 520 shares of the conglomerate’s stock valued at $103,000 after acquiring an additional 255 shares in the last quarter. Phraction Management LLC raised its position in shares of Danaher by 21.3% during the second quarter. Phraction Management LLC now owns 47,182 shares of the conglomerate’s stock worth $9,320,000 after purchasing an additional 8,280 shares during the period. Finally, Atwater Malick LLC lifted its holdings in shares of Danaher by 8.0% in the 2nd quarter. Atwater Malick LLC now owns 1,724 shares of the conglomerate’s stock worth $341,000 after purchasing an additional 127 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts recently issued reports on the stock. Wall Street Zen raised shares of Danaher from a “hold” rating to a “buy” rating in a research report on Friday, June 27th. UBS Group reduced their price objective on shares of Danaher from $240.00 to $225.00 and set a “buy” rating for the company in a report on Wednesday, July 23rd. Barclays reissued an “overweight” rating and set a $225.00 target price (up from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Royal Bank Of Canada set a $241.00 price target on shares of Danaher in a research report on Tuesday, September 2nd. Finally, Robert W. Baird lifted their price target on Danaher from $225.00 to $226.00 and gave the company an “outperform” rating in a research note on Friday, July 18th. Seventeen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $245.91.

Danaher Stock Up 2.2%

DHR opened at $215.05 on Friday. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $279.41. The firm has a market capitalization of $153.98 billion, a P/E ratio of 45.75, a PEG ratio of 3.06 and a beta of 0.77. The company’s 50-day moving average is $200.19 and its 200 day moving average is $197.33. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating the consensus estimate of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm had revenue of $5.94 billion during the quarter, compared to analyst estimates of $5.83 billion. During the same quarter last year, the business posted $1.72 EPS. The company’s revenue for the quarter was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Research analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 annualized dividend and a yield of 0.6%. Danaher’s payout ratio is currently 27.23%.

Insider Transactions at Danaher

In other news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares of the company’s stock, valued at $4,379,706.06. This trade represents a 11.81% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 11.10% of the stock is owned by company insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.